Next Article in Journal
Consensus Recommendations for Cancer Rehabilitation: Research and Education Priorities
Previous Article in Journal
Endocrine Therapy for Postmenopausal Women with Hormone Receptor–Positive her2–Negative Advanced Breast Cancer after Progression or Recurrence on Nonsteroidal Aromatase Inhibitor Therapy: A Canadian Consensus Statement
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 20
Issue 1
10.3747/co.20.1290
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Indicator Measures er/pr and her2 Testing among Women with Invasive Breast Cancer

by
C. Sandoval
1,
R. Rahal
1,
T. Forte
1,*,
J. Klein–Geltink
1,
D. He
1 and
H. Bryant
1,2
1
Canadian Partnership Against Cancer, Toronto, ON, Canada
2
Departments of Community Health Sciences and Oncology, University of Calgary, Calgary, AB, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2013, 20(1), 62-63; https://doi.org/10.3747/co.20.1290
Submission received: 3 November 2012 / Revised: 5 December 2012 / Accepted: 8 January 2013 / Published: 1 February 2013

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

As part of its System Performance initiative, the Canadian Partnership Against Cancer released Breast Cancer Control in Canada: A System Performance Special Focus Report in September 2012, presenting a broad range of system performance indicators that measure breast cancer control across the continuum. [...]

Share and Cite

MDPI and ACS Style

Sandoval, C.; Rahal, R.; Forte, T.; Klein–Geltink, J.; He, D.; Bryant, H. Indicator Measures er/pr and her2 Testing among Women with Invasive Breast Cancer. Curr. Oncol. 2013, 20, 62-63. https://doi.org/10.3747/co.20.1290

AMA Style

Sandoval C, Rahal R, Forte T, Klein–Geltink J, He D, Bryant H. Indicator Measures er/pr and her2 Testing among Women with Invasive Breast Cancer. Current Oncology. 2013; 20(1):62-63. https://doi.org/10.3747/co.20.1290

Chicago/Turabian Style

Sandoval, C., R. Rahal, T. Forte, J. Klein–Geltink, D. He, and H. Bryant. 2013. "Indicator Measures er/pr and her2 Testing among Women with Invasive Breast Cancer" Current Oncology 20, no. 1: 62-63. https://doi.org/10.3747/co.20.1290

APA Style

Sandoval, C., Rahal, R., Forte, T., Klein–Geltink, J., He, D., & Bryant, H. (2013). Indicator Measures er/pr and her2 Testing among Women with Invasive Breast Cancer. Current Oncology, 20(1), 62-63. https://doi.org/10.3747/co.20.1290

Article Metrics

Back to TopTop